RIPK3 and acute myeloid leukemia: Cell death mediated by receptor interacting protein kinase 3 (RIPK3) has a critical tumor-suppressive function during leukemogenesis [6] mediated by the induction of cell death and the inflammation-driven myeloid differentiation of the AML stem/progenitors [4, 6].